Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia. [electronic resource]
Producer: 20060425Description: 97-103 p. digitalISSN:- 0168-8278
- Adolescent
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Male
- Middle Aged
- Polyethylene Glycols
- Polymerase Chain Reaction
- RNA, Viral -- genetics
- Recombinant Proteins
- Ribavirin -- therapeutic use
- Time Factors
- Treatment Outcome
- Viremia -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.